SCHEMBL2059438

SCHEMBL2059438

CC(C)(C)OC(=O)[C@@H](C(N)c1ccccc1)[C@@H](O)C[C@@H](N)Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 1/20 0.42
ITGB7 P26010 1/20 0.42
KLK5 Q9Y337 2/20 0.42
EPHX1 P07099 2/20 0.40
PSEN1 P49768 3/20 0.39
PSEN2 P49810 3/20 0.39
APH1B Q8WW43 3/20 0.39
NCSTN Q92542 3/20 0.39
APH1A Q96BI3 3/20 0.39
PSENEN Q9NZ42 3/20 0.39
APP P05067 1/20 0.39
SLC7A5 Q01650 1/20 0.39
CHRM1 P11229 1/20 0.38
ATM Q13315 1/20 0.38
MAPT P10636 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
POLB P06746 2/20 0.38
ALDH1A1 P00352 1/20 0.38
RECQL P46063 1/20 0.38
PAX8 Q06710 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27892297 0.81 AAK1 (0.36) SLC7A5CHRM1ATMNPSR1LTA4H
SCHEMBL28535028 0.79 APP (0.41) ITGA4ITGB7KLK5PSEN1PSEN2
SCHEMBL28535029 0.79 APP (0.41) ITGA4ITGB7KLK5PSEN1PSEN2
SCHEMBL9833387 0.78 ALDH1A1 (0.41) ITGA4ITGB7KLK5ALDH1A1LTA4H
SCHEMBL8069348 0.78 ALDH1A1 (0.40) ITGA4ITGB7MAPTNPSR1ALDH1A1
SCHEMBL28301558 0.78 ADRA2A (0.40) ATMMAPTNPSR1ALDH1A1RECQL
SCHEMBL27613187 0.77 F10 (0.40) ALDH1A1
SCHEMBL7339294 0.77 PSMB5 (0.39) ITGA4ITGB7KLK5SLC7A5ATM
SCHEMBL5650824 0.77 ATM (0.38) SLC7A5ATMLTA4HCTSS
SCHEMBL5652634 0.77 ATM (0.38) SLC7A5ATMLTA4HCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968707-B2 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection ABBOTT LABORATORIES (US) 2011-06-28 US disclosed
US-20080139811-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBVIE INC. 2008-06-12 US disclosed
EP-1295874-A2 Retroviral protease inhibiting compounds Abbott Laboratories (US) 2003-03-26 EP disclosed
US-6472529-B2 VIRICIDES ABBOTT LABORATORIES 2002-10-29 US disclosed
EP-0882024-B1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LAB (US) 2002-02-06 EP disclosed
US-20020004503-A1 Retroviral protease inhibiting compounds ABBVIE INC. 2002-01-10 US disclosed
EP-1170289-A2 Retroviral protease inhibiting compounds Abbott Laboratories (US) 2002-01-09 EP disclosed
EP-0876353-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS Abbott Laboratories (US) 1998-11-11 EP disclosed
WO-1997021683-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1997-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139811-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS SERPINB1, PREP, DNPEP ITGA4 3986/4885ITGB7 2950/4885KLK5 1415/4885
US-20020004503-A1 Retroviral protease inhibiting compounds SERPINB1, PREP, TMPRSS15 ITGA4 4001/4885ITGB7 3106/4885KLK5 1558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.